[Poor response in patients with de novo acute myeloid leukemia and erythroblastic or megakaryocytic dysplasia to treatment with standard doses of cytosine arabinoside and daunorubicin].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples